TCL Archive NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period October 18, 1985
TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
TCL Archive In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR April 15, 1994
TCL Archive Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials July 11, 2003
TCL Archive Retraction Based On Data Given To Duke Last November, But Apparently Disregarded October 29, 2010
